ÃÊ´ç´ëÇб³ ÀǾà°ü¸®Çаú ÃÖÁø¼® ±³¼ö, ±¹Á¦Àü¹®ÇмúÁö(SCIE) ³í¹® °ÔÀç
ÃÖ¼ö¿¬ ±âÀÚ cym1771@naver.com
2025³â 10¿ù 10ÀÏ(±Ý) 14:18
ÃÊ´ç´ëÇб³ ÀǾà°ü¸®Çаú ÃÖÁø¼® ±³¼ö, ±¹Á¦Àü¹®ÇмúÁö(SCIE) ³í¹® °ÔÀç
[µ¥Àϸ®Àü³² = ÃÖ¼ö¿¬ ±âÀÚ] ÃÊ´ç´ëÇб³(ÃÑÀå ¼­À¯¹Ì) âÀÇÀ¶ÇÕ´ëÇÐ ÀǾà°ü¸®Çаú ÃÖÁø¼® ±³¼öÀÇ ³í¹®ÀÌ ±¹Á¦Àü¹®ÇмúÁö(SCIE)ÀÇ Àú³ÎÀÎ Pharmaceutical Research (Impact factor 4.3)¿¡ ¿¬±¸ ³í¹®ÀÌ 9¿ùÈ£¿¡ °ÔÀçµÇ¾ú´Ù.

³í¹®Á¦¸ñÀº ¡®Development of Candesartan Cilexetil‑sodium Carbonate anhydrate‑mesoporous Silica Solid Dispersion in Polymer‑free System¡¯ À¸·Î °íÇ÷¾ÐÄ¡·áÁ¦ÀÎ Ä­µ¥»ç¸£Åº ½Ç·º¼¼Æ¿À» °íºÐÀÚ ¹× °¡¿ëÈ­Á¦°¡ ¾øÀÌ ¿ë¸ÅÁõ¹ß¹ýÀ» ÀÌ¿ëÇÏ¿© °¡¿ëÈ­ ¹× ¾ÈÁ¤È­µÈ °íüºÐ»êü¸¦ °³¹ßÇÏ¿´´Ù.

º» ¿¬±¸´Â Á¤ºÎ(°úÇбâ¼úÁ¤º¸Åë½ÅºÎ)ÀÇ Àç¿øÀ¸·Î Çѱ¹¿¬±¸Àç´ÜÀÇ Áö¿øÀ» ¹Þ¾Æ ¼öÇàµÈ ¿¬±¸ÀÌ´Ù.

ÃÊ´ç´ëÇб³´Â ¸ð±â¾÷À¸·Î ¹éÁ¦¾àǰ(ÀǾàǰÀ¯Åë) ¹× ÃÊ´ç¾àǰ°ø¾÷(Á¦¾àȸ»ç)ÀÌ ÀÖÀ¸¸ç, ÀǾà°ü¸®Çаú ¹× À£´Ï½º¶óÀÌÇÁÇкÎ(ÀǾà°ü¸®Àü°ø)ÀÇ Ãë¾÷ Áø·Î´Â Á¦¾àȸ»ç(R&D, ǰÁú°ü¸®, ¿µ¾÷ ¹× ¸¶ÄÉÆÃ) ¹× º´¿øÇàÁ¤ÀÌ´Ù. ƯÈ÷, »óÀ§ 20À§±Ç Á¦¾àȸ»ç¸¦ Ãë¾÷ ¸ñÇ¥·Î »ï°í ÀÖ´Ù.
ÃÖ¼ö¿¬ ±âÀÚ cym1771@naver.com
ÀÌ ±â»ç´Â µ¥Àϸ®Àü³² ȨÆäÀÌÁö(dailyjn.kr)¿¡¼­ ÇÁ¸°Æ® µÇ¾ú½À´Ï´Ù.

URL : http://www.dailyjn.kr/article.php?aid=20230226516
ÇÁ¸°Æ® ½Ã°£ : 2025³â 11¿ù 16ÀÏ 08:53:41